Tiny Magnetic Robots Could Replace Open Heart Surgery With Targeted Drug Delivery

A new class of miniature, magnetically controlled robots could soon transform the treatment of life-threatening heart infections, potentially rendering invasive surgeries and long-term intravenous therapies obsolete. Researchers have developed “millirobots,” devices roughly the size of a pencil tip or a grain of rice, designed to navigate the human body and deliver concentrated medication directly to infected heart tissue.

The findings, recently published in Advanced Materials Technologies, describe a system that addresses the limitations of current endocarditis treatments. Every year, approximately 50,000 Americans suffer from this dangerous heart infection. Standard care currently involves weeks of systemic antibiotic treatment, which is often inefficient because the medication becomes heavily diluted before reaching the heart. When antibiotics fail, physicians are forced to choose between toxic high-dose regimens or high-risk open-heart surgery.

The robotic solution relies on a two-part system powered by external electromagnetic fields, similar to the technology utilized in MRI machines. This eliminates the need for onboard power sources like batteries or motors, allowing the devices to remain exceptionally small.

How the Robotic System Functions

The system utilizes two distinct, magnetically guided units that operate in tandem to ensure precision:

• The Needle Module: This unit acts as a secure docking station, latching onto the heart tissue at the exact site of the infection.
• The Drug Module: This second unit carries the therapeutic payload to the docking station, where it magnetically attaches to deliver medication directly to the target area.

According to Axel Krieger, a medical roboticist and senior author of the study, the dual-robot design allows for superior maneuverability in tight anatomical spaces. Because the needle module stays anchored, medical professionals can replace the drug module as needed, facilitating multiple doses without requiring further invasive procedures.

“With just a little pinprick, you insert a micro robot and do a procedure without infection or blood loss,” Krieger stated. “And you don’t need to have a surgeon operating it to get the drugs robustly, safely, and efficiently to the right place.”

Advancing Precision Medicine

Initial testing has been conducted using both phantom heart models and live porcine tissue. The robots demonstrated an ability to navigate autonomously, maintaining their course even when facing simulated blood flow. Researchers suggest that this technology could reduce the treatment timeline for heart infections from several weeks to less than a day.

Beyond cardiac applications, the research team believes these steerable robots could represent a significant frontier in surgical robotics, with potential future uses in delivering targeted therapies for cancer treatment. Anuruddha Bhattacharjee, the study’s first author and an assistant professor at the University of Alabama at Birmingham, emphasized the shift in patient care, noting that a procedure that once required a month-long hospital stay could potentially be completed in under an hour.

The research group, which includes experts from Johns Hopkins University, the University of Maryland, and Weinberg Medical Physics, plans to expand their testing to incorporate more complex heart models that account for the dynamic, rhythmic movements of a beating heart. The project is supported by the National Science Foundation’s Foundational Research in Robotics CAREER program.